Loxapine

Product NDC
70518-2120
11-digit product format
705182120
Labeler code
70518
Product ID
70518-2120_c6244a20-ce78-2179-e053-2995a90a6751
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Loxapine
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA090695
Marketing category
ANDA
Marketing start
2019-05-28
Marketing end
0000-00-00
Substance
LOXAPINE SUCCINATE
Active strength
5 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2120-02023-03-07C16284748780-1f386c64a-2915-0266-e053-dadaa90a7c1ade242545-3e3a-4517-90db-7355650effef
70518-2120-02023-01-30C16284748780-1f386c64a-2915-0266-e053-dadaa90a7c1ade242545-3e3a-4517-90db-7355650effef

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2120-07051821200030 CAPSULE in 1 BLISTER PACK (70518-2120-0) 30 capsule2019-05-280000-00-00NoNoCurrent